Hyper-Transmissible SARS-CoV-2 Variant Detected in United States Wastewater

▴ Hyper-Transmissible SARS-CoV-2 Variant Detected in United States Wastewater
GT Molecular, a leader in wastewater-based epidemiological testing, has reported the detection of hyper-transmissible SARS-CoV-2 from the B.1.1.7 lineage in three wastewater treatment plants in the United States.

GT Molecular, a leader in wastewater-based epidemiological testing, has reported the detection of hyper-transmissible SARS-CoV-2 from the B.1.1.7 lineage in three wastewater treatment plants in the United States. This is an additional piece of evidence that the UK variant or a UK variant-like strain is spreading in the United States. GT Molecular detected the strain using its highly sensitive digital PCR test for the SARS-CoV-2 virus. This test is available immediately both as a fee-for-service and as a complete, ready-to-use PCR kit for testing labs.

"Molecular biologists from around the world have come together to advance wastewater-based epidemiological approaches over the last year. This is an excellent demonstration of the power of these approaches, wherein an entire community can be tested for the presence of a variant in a single sample in a matter of hours," says, Dr. Rose Nash, Director of R&D at GT Molecular.

GT Molecular will continue to screen communities around the country for the presence of this variant in their community wastewater through their nationwide wastewater testing program. Additionally, GT Molecular will provide the molecular reagents they designed and optimized for this analysis to the greater wastewater-based epidemiology community.

"Our team continues to respond rapidly to this pandemic by releasing both a fee-for-service test for communities and an all-in-one PCR kit for testing labs for this dangerous variant," says GT Molecular CEO Christopher McKee. "Our new analysis will allow communities and testing labs to quickly determine whether the SARS-CoV-2 B.1.1.7 variant is present while giving health officials timely data to make decisions that can better help manage outbreaks."

About GT Molecular

Whether for cancer, GMO, or harmful pathogens, GT Molecular (GTM) is a leader in providing highly customizable, ultrasensitive digital PCR and qPCR tests for researchers and the Molecular Diagnostics community. GTM's molecular app technology is an easy-to-use, end-to-end solution for rapid deployment and provides reliable and consistent measurements while detecting as little as 1-3 molecules of target nucleic acid.

Tags : #GTMolecular #UnitedStates #CovidInfection #Hyper-TransmissibleSARS-CoV-2Variant #wastewaterTreatmentplants #SARS-CoV-2virus #PCRKITS #Covid-19

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Beating Moyamoya: How Timely Surgery Transformed an 11-Year-Old’s LifeJanuary 17, 2025
Glaucoma Awareness Month: A Closer Look at the Silent Thief of SightJanuary 17, 2025
The $1,349 Million Question: Can India’s Nutritional Intervention End TB?January 17, 2025
Cutting-Edge Cancer Detection: ErlySign’s Saliva Test ExplainedJanuary 17, 2025
Refurbished Medical Devices Banned: Is India’s Healthcare System Ready for the Shift?January 17, 2025
Sharp Sight Eye Hospitals joins hand in Mahakumbh 2025 with Netra Kumbh: The World’s Largest Free Eye Check-Up CampJanuary 16, 2025
11-Year-Old Overcomes Guillain-Barré Syndrome After a Month-Long Battle January 16, 2025
Empowering Through Education: Himalaya Wellness Concludes second edition of 'My First Pimple' CampaignJanuary 16, 2025
BLACK+DECKER™ enters the Indian Smart TV market with its first-ever 4K Google TV featuring a Sleek Frameless Design and Next-Level Entertainment in association with Indkal Technologies Pvt. LtdJanuary 16, 2025
Driving Innovation and Growth: Insights from Startup Leaders on National Startup Day | MedRabbits HealthcareJanuary 16, 2025
Death at Medinipur: How A Mother’s Loss Exposes the Cracks in India’s Healthcare SystemJanuary 16, 2025
Could Engineered Cells Be the Cure-All Medicine We’ve Been Waiting For?January 16, 2025
15 innovative Social Impact Start-ups selected for incubation by BHARAT IMPACT - an initiative of Jubilant Bhartia FoundationJanuary 15, 2025
Budget expectations from Vikram Vuppala Founder and CEO, NephroPlusJanuary 15, 2025
Why do headaches worsen in the winter season? 5 remedies to treat themJanuary 15, 2025
Fleetguard Filters Private Limited (FFPL) undertakes a mega plantation drive under its CSR Initiative at Village Tamhanwadi, Daund January 15, 2025
Two-thirds of India’s Working Age Hit by NCDs: Can We Reverse the Tide?January 15, 2025
Outdated and Inaccurate: Why BMI Can’t Measure True HealthJanuary 15, 2025
Entertainment vs. Heart Health: Is Bedtime Reel Scrolling Worth the Risk? January 15, 2025
6 Reasons Why Exercising Fuels a Better Mind & BodyJanuary 15, 2025